4.69MMarket Cap-270P/E (TTM)
1.6900High1.6299Low24.10KVolume1.6299Open1.6300Pre Close39.74KTurnover0.97%Turnover RatioLossP/E (Static)2.86MShares18.000052wk High0.53P/B4.07MFloat Cap1.400052wk Low--Dividend TTM2.48MShs Float284.7980Historical High--Div YieldTTM3.69%Amplitude1.4000Historical Low1.6490Avg Price1Lot Size
Processa Pharmaceuticals Stock Forum
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
Processa Pharmaceuticals has announced positive results from their Phase 1b trial of NGC-Cap in gastrointestinal cancer patients. The trial involved 12 patients, with 66.7% achieving progression-free survival (PFS) ranging from 5 to 11 months. At the highest dose, all patients showed PFS, with tw...
Larger Image: tradingview.com...
$Processa Pharmaceuticals(PCSA.US)$
No comment yet